Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  British Journal of Surgery

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/bjs.8679PMID 22287157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new standard of care for the management of peritoneal surface malignancy.

  2011cited by this paper
• How important is peritoneal involvement in rectal cancer? A prospective study of 331 cases

  2010cited by this paper
• Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study.

  2010cited by this paper
• Revised guidelines for second-look surgery in patients with colon and rectal cancer

  2010cited by this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis

  2010cited by this paper
• Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases

  2010cited by this paper
• Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia in Patients With Colorectal Cancer at High Risk for Local-Regional Recurrence

  2009cited by this paper
• Long-Term Results of Cytoreduction and HIPEC Followed by Systemic Chemotherapy

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer

  2009cited by this paper
• An interim analysis of recruitment to the COLOFOL trial

  2009cited by this paper
• Results of Systematic Second-Look Surgery in Patients at High Risk of Developing Colorectal Peritoneal Carcinomatosis

  2008cited by this paper
• Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies

  2006cited by this paper
• Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study

  2004cited by this paper
• Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

  2003cited by this paper
• Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer

  2002cited by this paper
• Peritoneal carcinomatosis from colorectal cancer

  2002cited by this paper
• Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy

  1995cited by this paper
• TNM Classification of Malignant Tumours

  1987cited by this paper
• Obstructive and perforative colonic carcinoma: patterns of failure.

  1985cited by this paper
• Adenocarcinoma of the sigmoid colon: Sites of initial dissemination and clinical patterns of recurrence following surgery alone

  1983cited by this paper

• Combined Intraperitoneal and Systemic Chemotherapy for Peritoneal Metastases: Drug Delivery Concepts, Pharmacokinetics, and Clinical Applications: A Narrative Review.

  2026cites this paper
• A short-term, exploratory randomized controlled trial on the safety and feasibility of intraoperative raltitrexed peritoneal chemotherapy in laparoscopic radical resection for advanced colorectal cancer.

  2026cites this paper
• Diagnostic value of contrast-enhanced CT in detecting peritoneal metastasis from colorectal cancer: a comparative study with surgical and pathological findings.

  2026cites this paper
• PDK4-driven metabolic reprogramming enhances mesothelial cell invasion in colorectal cancer peritoneal metastasis.

  2026cites this paper
• Predictors of Peritoneal Surface Recurrence and Quantitative Association with Time to Relapse After Complete CRS/HIPEC for Colorectal Peritoneal Metastasis

  2026cites this paper
• What is worth knowing about peritoneal metastases in colorectal cancer?

  2026cites this paper
• Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection?

  2026cites this paper
• Survival and morbidity in elderly patients treated with cytoreductive surgery and HIPEC for colorectal peritoneal metastases: a population-based study.

  2026cites this paper
• Metastatic prostate cancer mimicking colorectal cancer: a rare case of peritoneal and mesocolic lymph node involvement

  2026cites this paper
• Lutetium‐Based Nanoprobes for Radiosensitization with Immune Microenvironment Remodeling and NIR‐II Fluorescence Imaging‐Guided Surgery in Colorectal Cancer

  2025cites this paper
• Efficacy and safety of subtotal pelvic peritonectomy for colorectal cancer patients with peritoneal metastasis confined to the pelvic cavity.

  2025cites this paper
• Peritoneal Oligometastasis in Gastric Cancer: Diagnostic Strategies, Patient Selection, and Emerging Therapeutic Approaches

  2025cites this paper
• Real‐Time, AI‐Guided Photodynamic Laparoscopy Enhances Detection in a Rabbit Model of Peritoneal Cancer Metastasis

  2025cites this paper
• Clinical and Pathological Risk Factors for Peritoneal Metastases in a Surgical Series of T4 Colorectal Cancers

  2025cites this paper
• The impact of surgical staging in patients with colorectal peritoneal metastases scheduled for CRS-HIPEC

  2025cites this paper
• A Novel Approach in Colon Cancer Treatment Successful Conversion of Locally Advanced Colon Cancer Using Endoscopic Rendezvous Technique Combined with Multimodal Therapy-A Case Report and Literature Review.

  2025cites this paper
• Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.

  2025cites this paper
• A Rare Case of Colorectal Cancer With Delayed Metastasis to the Duodenum

  2025cites this paper
• The Outcome of Colonoscopy-Assisted Laparoscopic Wedge Resections (CAL-WR) for Colon Cancer: A Retrospective Cohort Study

  2025cites this paper
• Consensus guideline for the management of colorectal cancer with peritoneal metastases

  2025cites this paper
• Microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells promotes peritoneal metastasis of colorectal cancer

  2025cites this paper
• Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis

  2025cites this paper
• Pressurized intraperitoneal aerosol chemotherapy in advanced colorectal cancer with peritoneal metastases: a meta-analysis of feasibility, efficacy, and safety

  2025cites this paper
• Peritoneal reflection involvement as a prognostic factor in rectal cancer. Long-term oncological outcomes from a prospective study

  2025influential citation
• Long-term survival of a patient with colorectal cancer with peritoneal carcinomatosis and low completeness of cytoreduction score: A case report

  2025cites this paper
• Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?

  2025cites this paper
• Colorectal cancer peritoneal metastasis is promoted by tissue-specific fibroblasts that can arise in response to various local disorders.

  2025cites this paper
• Prognostic Impact of Potentially Curative Resection for Synchronous Peritoneal Carcinomatosis with Lavage Cytology Positivity in Colorectal Cancer: A Retrospective Observational Study

  2025cites this paper
• Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives

  2025cites this paper
• The epidemiology, current evidence and controversies in diagnosis and management of patients with colorectal peritoneal metastases.

  2025cites this paper
• Risk of peritoneal recurrence following laparoscopic versus open surgery for stage II/III colorectal cancer: An integrated analysis of three Phase III randomized controlled trials (JCOG2310AS2).

  2025cites this paper
• Peritoneal Cancer Index Dominates Prognosis After CRS–HIPEC for Colorectal Peritoneal Metastases: A Consecutive Single-Centre Cohort with 3-Year Follow-Up

  2025cites this paper
• Anastomosis versus rectal stump procedure in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal peritoneal metastases: A comparative study

  2025cites this paper
• Discovery of circulating cell-free DNA 5hmC biomarkers for peritoneal metastasis in colorectal and appendiceal cancer

  2025cites this paper
• Case report of sigmoid colon cancer with synchronous peritoneal metastasis achieving a pathological complete response after mFOLFOX6 plus cetuximab

  2025cites this paper
• Operative Techniques, Current Controversies, and Future Directions in the Surgical Management of Liver, Lung, and Peritoneal Metastases in Colorectal Cancer

  2025influential citation
• Radiologic and Pathologic Response as Predictors of Survival in Patients with Colorectal Peritoneal Metastases Undergoing Neoadjuvant Chemotherapy Followed by CRS-HIPEC: A Retrospective Study

  2025cites this paper
• Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal malignancy—outcomes and learning curves in medium volume center

  2025cites this paper
• Immunotherapy Plus Surgery Improves Survival in Microsatellite Instability-High Colon Cancer with Isolated Peritoneal Metastases

  2025cites this paper
• Characteristics of 18F-FAPI-04 PET/CT in patients with peritoneal metastasis and to predict treatment efficacy, a head-to-head comparison with 18F-FDG PET/CT

  2025cites this paper
• What is the accuracy, sensitivity and specificity of the radiological peritoneal cancer index in repeat cytoreductive surgery: a retrospective study

  2025influential citation
• The Role of Prophylactic or Adjuvant Hyperthermic Intraperitoneal Therapy in Appendiceal and Colorectal Cancer Peritoneal Metastasis.

  2025cites this paper
• Safe skills transfer and mentorship: The all‐Wales colorectal peritoneal metastasis service—A collaborative strategy to develop a new national service

  2025cites this paper
• Neoadjuvant treatment of colorectal cancer: comprehensive review

  2024cites this paper
• Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data.

  2024cites this paper
• Metastasis-associated fibroblasts in peritoneal surface malignancies

  2024cites this paper
• Identification of an Objective Cut-Off Point to Define the Clinical Stage T4a in Colon Cancer

  2024cites this paper
• Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer.

  2024cites this paper
• Long noncoding RNA small nucleolar RNA host gene 1 as a potential novel biomarker for intraperitoneal free cancer cells in colorectal cancer

  2024cites this paper
• Anastomotic leakage following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A clinical cohort study.

  2024cites this paper
• Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases

  2024cites this paper
• Developing a Core Outcome Set for Cytoreductive Surgery for Colorectal Cancer with Peritoneal Metastases: A Mixed-Method Study Protocol

  2024cites this paper
• Prophylactic hyperthermic intraperitoneal chemotherapy in T4 colorectal cancer: Can it improve the oncologic prognosis? - A propensity score matching study.

  2024cites this paper
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal Cancer—An Overview of Current Status and Future Perspectives

  2024influential citation
• Atypical new-onset ascites due to a rare variant of cecal carcinoma in a patient with a ventriculoperitoneal shunt: A case report

  2024cites this paper
• Treatment of Oligometastatic GI Cancers.

  2024cites this paper
• Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

  2024influential citation
• Novel biotargets of colorectal cancer peritoneal metastasis

  2024cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A pragmatic comparison of oncological outcomes in synchronous versus metachronous disease.

  2024cites this paper
• Systemic Chemotherapy in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery: Systematic Review and Meta-Analysis

  2024cites this paper
• An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer

  2024cites this paper
• A systematic review of population-based studies on metachronous metastases of colorectal cancer.

  2024cites this paper
• Reported outcomes following cytoreductive surgery for colorectal peritoneal metastases: A systematic review to inform evidence‐based practice and international consensus

  2024cites this paper
• Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden

  2024cites this paper
• The Use of CellCollector Assay to Detect Free Cancer Cells in the Peritoneal Cavity of Colorectal Cancer Patients: An Experimental Study

  2024cites this paper
• Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis in Colorectal Cancer Patients: A Systematic Review of the Evidence

  2024cites this paper
• Appendiceal adenocarcinoma-patterns of tumor spread and prognosis.

  2024cites this paper
• The clinical impact of intraoperative bleeding on peritoneal recurrence after surgery for stage II to III colorectal cancer.

  2024cites this paper
• Eighteen‐Months Safety and Efficacy Following Intraperitoneal Treatment With 224Radium‐Labeled Microparticles After CRS‐HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer

  2024cites this paper
• Research progress of epithelial-mesenchymal transformation-related transcription factors in peritoneal metastases

  2024cites this paper
• Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index.

  2024cites this paper
• The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis

  2024cites this paper
• Hyperthermic intraoperative peritoneal chemotherapy and cytoreductive surgery for people with peritoneal metastases: a systematic review and cost-effectiveness analysis.

  2024cites this paper
• Sulfatide imaging identifies tumor cells in colorectal cancer peritoneal metastases

  2024influential citation
• The Ugly: Metastatic Colon Cancer—Surgical Options

  2024cites this paper
• Enhancing precision in colorectal cancer surgery: development of an LGR5-targeting RSPO1 peptide mimetic as a contrast agent for intraoperative fluorescence molecular imaging

  2024cites this paper
• Cytoreductive surgery without intra-peritoneal chemotherapy for metachronous colorectal peritoneal metastases

  2024influential citation
• Cancer spreading patterns based on epithelial-mesenchymal plasticity

  2024cites this paper
• Imaging in malignant peritoneal neoplasms

  2024cites this paper
• Medicaid Expansion and Overall Survival of Lower Gastrointestinal Cancer Patients After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy

  2024cites this paper
• Risk of metachronous peritoneal metastases after surgery for obstructive colon cancer: Multivariate analysis from a series of 1,085 patients.

  2024cites this paper
• Effectiveness of hyperthermic intraperitoneal chemotherapy during primary curative resection for colorectal carcinoma

  2024cites this paper
• Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: A systematic review of randomized controlled trials

  2024cites this paper
• First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)

  2023cites this paper
• Epidemiology of Stage IV Colorectal Cancer: Trends in the Incidence, Prevalence, Age Distribution, and Impact on Life Span

  2023cites this paper
• Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases

  2023cites this paper
• Comparative Study of Short-Term Efficacy and Safety of Mitomycin versus Lobaplatin for Hyperthermic Intraperitoneal Chemotherapy after Radical Surgery in Colorectal Cancer with High-Risk Factors for Peritoneal Carcinomatosis: A Propensity Score Matching Analysis

  2023cites this paper
• DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review

  2023cites this paper
• The molecular biology of peritoneal metastatic disease

  2023cites this paper
• Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies—A Comprehensive Review

  2023cites this paper
• Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians

  2023cites this paper
• Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers

  2023cites this paper
• NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody

  2023cites this paper
• Therapie peritonealer Metastasen

  2023cites this paper
• Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer.

  2023cites this paper
• Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2023cites this paper
• Prevalence, patterns, risk factors and outcomes of peritoneal metastases after laparoscopic hepatectomy for hepatocellular carcinoma: a multicenter study from China

  2023cites this paper
• International Expert Consensus on Defining Textbook Oncologic Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis.

  2023cites this paper
• Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer

  2023cites this paper
• The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer

  2023cites this paper